The regulator releases the list of “not of standard quality” drugs every ... These included popular fever drugs, painkillers, and allergy tablets. Earlier in February, the DCGI Rajeev Raghuvanshi ...
(NASDAQ: GNLN) has entered the battle against dangerous drugs, but not only against opioids. Greenlane announced this week its plans to launch an all-new line of fentanyl, xylazine and drink spike ...
Investorideas.com ( a go-to investing platform covering cannabis stocks releases an industry snapshot looking at the battle against dangerous drugs, including fentanyl, featuring Greenlane Holdings, ...